These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 6144211)
1. [Therapeutic value of antihistamines today. Dermatoses and allergic diseases of the mucous membranes]. Stüttgen G; Blitstein-Willinger E; Rudolph R Z Hautkr; 1984 Mar; 59(6):355-66. PubMed ID: 6144211 [TBL] [Abstract][Full Text] [Related]
2. H1-antihistamines in children. Simons FE Clin Allergy Immunol; 2002; 17():437-64. PubMed ID: 12113226 [TBL] [Abstract][Full Text] [Related]
3. Rupatadine for the treatment of allergic rhinitis and urticaria. Metz M; Maurer M Expert Rev Clin Immunol; 2011 Jan; 7(1):15-20. PubMed ID: 21162645 [TBL] [Abstract][Full Text] [Related]
4. [The rebirth of the H1-antagonists]. Sabbah A Allerg Immunol (Paris); 1992 Jun; 24(6):224-30. PubMed ID: 1379813 [TBL] [Abstract][Full Text] [Related]
6. [Histryl--a new antihistaminic drug]. Bernhardt E Przegl Dermatol; 1969; 56(4):501-3. PubMed ID: 4390954 [No Abstract] [Full Text] [Related]
7. [The place of antihistaminics in the modern therapy of allergy]. Wodniansky P Wien Klin Wochenschr; 1970 Mar; 82(10):178-80. PubMed ID: 4399721 [No Abstract] [Full Text] [Related]
9. H1-antihistamines in the elderly. Kaliner MA Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227 [TBL] [Abstract][Full Text] [Related]
10. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria. Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic idiopathic urticaria unresponsive to type 1 antihistamines in monotherapy]. Mateus C Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S129-44. PubMed ID: 12843818 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of H1-antihistamines. Blaiss MS Clin Allergy Immunol; 2002; 17():319-36. PubMed ID: 12113222 [TBL] [Abstract][Full Text] [Related]
13. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Sansom JE; Brooks J; Burton JL; Archer CB Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766 [TBL] [Abstract][Full Text] [Related]
14. [Status of antihistaminics in the therapy of bronchial asthma]. Kohl FV Z Hautkr; 1988; 63 Suppl 4():21-5. PubMed ID: 2908088 [TBL] [Abstract][Full Text] [Related]
15. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200 [TBL] [Abstract][Full Text] [Related]
16. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist]. Molkhou P Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness of a new antihistaminic, derivative of benzhydryl ether (HS 592), in various allergic diseases]. Stroescu V; Popescu IG; Dumitrescu C Stud Cercet Med Interna; 1969; 10(4):365-9. PubMed ID: 4391855 [No Abstract] [Full Text] [Related]
18. [H2-antagonists and possibilities for their therapeutic use in dermatology]. Diller G; Orfanos CE Hautarzt; 1982 Oct; 33(10):521-8. PubMed ID: 6130053 [TBL] [Abstract][Full Text] [Related]